IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#4295
Positioning
Market Dominance
Manufacturing
Candy & Soda
$697M
Cyril A. Wallace, Jr.
We are a branded beverage company offering a portfolio of natural, premium, and functional beverages under the Reed’s and Virgil’s brands. Our products are sold in over 32,000 outlets across the United States and in select international markets. Our principal executive office is located in Norwalk, Connecticut.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$UL UNILEVER PLC | 78 | 96 | 98 | 59 | - | - | 28.5% | 8.0% | 100.0% | 100.0% | 10.4% | -4.6% | 3.3% | 0.0x | $141.8B | VS | |
$ASML ASML HOLDING NV | 77 | 89 | 86 | 83 | - | - | 46.1% | 16.6% | 51.3% | 31.9% | 26.8% | -4.0% | 1.0% | 25.0x | $272.1B | VS | |
$ESLT ELBIT SYSTEMS LTD | 76 | 81 | 87 | 85 | - | - | 10.3% | 3.1% | 24.1% | 7.2% | 4.7% | 14.3% | 0.8% | 25.0x | $11.4B | VS | |
$MT ArcelorMittal | 75 | 71 | 98 | 85 | - | - | 2.2% | 1.5% | 9.3% | 5.3% | 2.2% | -8.5% | 2.2% | 16.0x | $18.9B | VS | |
$AMAT APPLIED MATERIALS INC /DE | 75 | 85 | 87 | 84 | 20.9x | 13.6x | 35.5% | 19.8% | 48.7% | 29.2% | 24.7% | 4.4% | 0.8% | 32.0x | $181.9B | VS | |
$SIMO Silicon Motion Technology CORP | 75 | 84 | 86 | 85 | - | - | 11.8% | 8.8% | 45.9% | 11.3% | 11.1% | 25.7% | 3.7% | 0.0x | $1.8B | VS | |
$CODA Coda Octopus Group, Inc. | 74 | 83 | 90 | 79 | 16.3x | 11.9x | 7.6% | 7.0% | 66.5% | 17.1% | 15.6% | 39.0% | 0.0% | 0.0x | $115M | VS | |
$GSK GSK plc | 74 | 84 | 90 | 70 | - | - | 22.6% | 4.9% | 71.2% | 12.8% | 9.4% | 1.7% | 5.9% | 124.0x | $72.1B | VS | |
$EFXT Enerflex Ltd. | 74 | 80 | 91 | 83 | - | - | 3.0% | 1.1% | 20.9% | 7.3% | 1.3% | 3.0% | 0.9% | 67.0x | $1.2B | VS | |
$BUD Anheuser-Busch InBev SA/NV | 74 | 84 | 97 | 63 | - | - | 8.2% | 3.5% | 55.3% | 25.9% | 12.4% | 0.7% | 1.7% | 0.0x | $87.0B | VS | |
$REED REED'S, INC. | 33 | 23 | 50 | 25 | - | - | -588.0% | -81.4% | 19.4% | -45.8% | -50.5% | -40.8% | 0.0% | 361.0x | $697M | ||
| SECTOR BENCH | - | - | - | - | - | 22.3x | 11.5x | -2.5% | -0.1% | 42.5% | 1.3% | -0.2% | 5.9% | 0.0% | 0.2x | - | REF |
REED'S, INC. (REED) receives a "Avoid" rating with a composite score of 33.1/100. It ranks #4295 out of 7,333 stocks in our coverage universe and carries a 1-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
Cyril A. Wallace, Jr.
Chief Executive Officer
Labor Force
24
23
30
30
Audit Verdict: Lower quality and stability scores may indicate governance concerns.
No recent insider transactions available for REED
Lagging peers — losers tend to keep underperforming
Fair valuation relative to peers
Weak fundamentals — higher risk of value trap
High volatility — wider range of outcomes increases timing risk
Aggressive spending — empire-building risk, dilutive growth
Below-average composite — caution warranted
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Manufacturing sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
No analyst ratings for REED.
View All RatingsMaterial decline in asset turnover efficiency detected
High margin volatility — erratic forensic earnings quality
ROIC -55.6% vs WACC 7.5% (spread -63.1%)
GM 19% vs sector 43%, OM -46% vs sector 1%
Capital turnover 1.21x
Rev growth -41%, 10yr history
Interest coverage -15.0x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
Our quantitative model flags REED'S, INC. with an Avoid rating, assigning a composite score of 33.1/100 and 1 out of 5 stars. Ranked #4295 of 7,333 stocks, REED falls in the bottom tier across key factors. Historically, stocks with this profile have faced elevated risk of underperformance and capital loss.
REED'S, INC. registers a weak quality score of just 23/100, indicating significant profitability challenges. The company reports a return on equity of -588.0% (sector avg: -2.5%), gross margins of 19.4% (sector avg: 42.5%), net margins of -50.5% (sector avg: -0.2%). Low quality scores are often associated with businesses in turnaround mode, early-stage growth, or structurally challenged industries.
REED's value score of 50/100 indicates the stock is fairly valued based on its current fundamentals. Key valuation metrics include a P/B ratio of 8.59x. At this level, neither a clear bargain nor overpriced, the stock's attractiveness depends more on forward growth expectations and qualitative factors.
REED'S, INC.'s investment score of 30/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of -40.8% vs. a sector average of 5.9% and a return on assets of -81.4% (sector: -0.1%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
REED'S, INC. is experiencing notably weak momentum with a score of just 25/100. The stock has underperformed its peers and is trending below major moving averages. Revenue growth stands at -40.8% year-over-year, while a beta of -0.59 reflects its sensitivity to broader market moves. While deep momentum weakness can occasionally present value opportunities, it often reflects deteriorating fundamentals or structural headwinds that may persist.
REED's stability score of 30/100 signals elevated volatility and/or leverage concerns. Key stability metrics include a beta of -0.59 and a debt-to-equity ratio of 361.00x (sector avg: 0.2x). Investors should be prepared for wider-than-average price swings and consider position sizing accordingly to manage portfolio risk.
The short interest score of 56/100 for REED suggests somewhat elevated bearish positioning by institutional traders. Specific risk factors include elevated leverage (D/E: 361.00x), small-cap liquidity risk. With a $697M market cap (small-cap), REED'S, INC. may experience above-average volatility. Investors should consider whether the short thesis has merit or if it creates a potential short-squeeze opportunity.
REED'S, INC. is a small-cap company in the Manufacturing sector, ranked #0 of 50 in its sector (100th percentile) and #4295 of 7,333 overall (41st percentile). Key comparisons include ROE of -588.0% trailing the -2.5% sector median and operating margins of -45.8% below the 1.3% sector average. This top-quartile standing reflects exceptional competitive strength relative to Manufacturing peers.
While REED currently exhibits a AVOID profile, superior opportunities exist within the MANUFACTURING sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Manufacturing Alpha →Quant Factor Profile
Upgrade catalyst
Improvement in Quality (23) would have the largest impact on the composite score.
ROE 23609% ABOVE SECTOR MEDIAN (FAVORABLE)
Gross Margin 54% BELOW SECTOR MEDIAN
Op. Margin 3647% BELOW SECTOR MEDIAN
AUDIT DATA AS OF SEP 30, 2025 (Q2 FY2025)
We rate REED'S, INC. (REED) as Avoid with a composite score of 33.1/100 at a current price of $2.30. The stock falls in the bottom quintile of our universe across key quantitative factors, and the multi-factor weakness suggests a high probability of continued underperformance.
The rating is primarily driven by strength in value (50th percentile) and stability (30th percentile), which together account for the majority of the composite score. Offsetting weakness in quality (23th percentile) and momentum (25th percentile) tempers our overall conviction. We assign a No Moat rating (12/100), Very High uncertainty, and Poor capital allocation.
Key items to watch: momentum to confirm whether the current price trend has legs; balance sheet deleveraging progress; the path to profitability. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
REED'S, INC. holds a top-quartile position (#0 of 50) within the Manufacturing sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 33.1/100 places it at rank #4295 in our full 7,333-stock universe. At $697M in market capitalization, REED'S, INC. is a small-cap player in the Manufacturing space, which limits certain scale advantages but may allow for more agile strategic execution.
Revenue contraction of -41% combined with momentum at the 25th percentile paints a cautious picture of the near-term business outlook. The market appears to be pricing in continued challenges, and a catalyst for reversal is not clearly visible from current data.
The margin cascade tells an important story: gross margins of 19% (-23.1pp vs sector) narrow to operating margins of -46% (-47.0pp vs sector) and net margins of -50.5%, yielding a gross-to-net conversion rate of -260%. The significant margin erosion from gross to net suggests elevated operating expenses, high interest costs, or other structural drags that warrant monitoring.
At a current price of $2.30, REED'S, INC. is trading near fair value based on current fundamentals. Our value factor score of 50/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. Valuation metrics are mixed, with no strong signal of mispricing in either direction.
The stock currently trades at P/B of 8.6x, P/S of 0.7x. We evaluate these multiples in the context of both absolute levels and sector-relative positioning to form our valuation view.
The stock may offer contrarian value if near-term headwinds prove transitory — the current weakness in factor scores may reverse if business fundamentals stabilize.
The Avoid rating (composite 33.1/100) reflects multi-factor weakness, and historically, stocks in this scoring range have underperformed the market by a meaningful margin.
Elevated leverage (361% D/E) amplifies downside risk and limits management's financial flexibility in adverse scenarios.
Revenue decline of -41% signals business deterioration — declining revenues make it difficult to grow into the current valuation and often precede further negative revisions.
Thin net margins of -50.5% provide limited cushion against cost pressures, competitive pricing, or macroeconomic headwinds — even small changes in costs could swing the company to a loss.
We assign a Very High uncertainty rating to REED'S, INC.. The stock exhibits multiple compounding risk factors: significant leverage (361% debt-to-equity), current negative profitability (net margin -50.5%), below-average price stability (30th percentile). The extreme uncertainty around future cash flows makes precise valuation difficult, and the range of outcomes is exceptionally wide. Only investors with high risk tolerance and extended time horizons should consider this name.
Specific risk factors that inform our assessment include: significant leverage (361% debt-to-equity); current negative profitability (net margin -50.5%); below-average price stability (30th percentile); weak quality scores (23th percentile). Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 30th percentile and quality factor at the 23th percentile provide a quantitative summary of the overall risk landscape.
We identify limited risk mitigants at this time, which contributes to our very high uncertainty assessment. Investors should monitor for improvement in balance sheet metrics, margin stability, and business predictability that could warrant a downgrade in our risk assessment over time.
We rate REED'S, INC.'s capital allocation as Poor. Key concerns include low returns on equity (-588.0%), elevated leverage (361% D/E), negative profitability, weak asset returns (ROA -81.4%). Exemplary capital allocators generate ROE above 20% and maintain conservative leverage — REED'S, INC. significantly underperforms these benchmarks, raising questions about management's ability to create shareholder value.
Investors should scrutinize management's reinvestment decisions and balance sheet trajectory before committing capital. Poor capital allocation often compounds over time: overlevered balance sheets limit strategic flexibility, while low returns on capital destroy shareholder value. We would need to see sustained improvement in profitability metrics and balance sheet discipline before considering an upgrade.
In summary, REED'S, INC. receives a Avoid rating with a composite score of 33.1/100 (rank #4295 of 7,333). Our quantitative framework assigns a No Moat (12/100, trend: stable), Very High uncertainty, and Poor capital allocation. The average factor score across quality, value, momentum, stability, and investment is 32/100.
Our analysis does not support a constructive view on REED'S, INC. at this time. The combination of limited competitive advantages, very high uncertainty, and poor capital allocation suggests unfavorable risk-reward at current levels. We recommend investors avoid new positions and existing holders consider reducing exposure.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We do not assign REED'S, INC. a meaningful economic moat, scoring 12/100 on our composite assessment. The ROIC-WACC spread of -63.1% is the primary signal of economic value creation. Current fundamentals do not demonstrate the kind of durable competitive advantages — such as superior returns on invested capital, margin superiority, or reinvestment efficiency — that would protect the company from competitive erosion over the long term. The highest-scoring pillar, margin superiority, reached only 5.9/20.
The strongest moat sources are margin superiority (5.9/20) and reinvestment efficiency (2.8/20). GM 19% vs sector 43%, OM -46% vs sector 1%. Capital turnover 1.21x. These pillars form the core of REED'S, INC.'s competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include economic value creation (0/20) and financial resilience (0/20). ROIC -55.6% vs WACC 7.5% (spread -63.1%). Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect REED'S, INC.'s moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include declining revenues (-41%) that pressure the earnings outlook. The margin cascade from 19% gross to -46% operating to -50.5% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that profit quality raises some durability concerns, with the quality factor at the 23th percentile.
The margin profile shows gross margins of 19%, operating margins of -46%, net margins of -50.5%. Return metrics include ROE of -588.0% and ROA of -81.4%. Relative to the Manufacturing sector, gross margins are 23.1 percentage points below the sector median of 43%, and ROE of -588.0% compares to a sector median of -2.5%.
The balance sheet reflects high leverage with D/E of 361%, which may limit financial flexibility, revenue growth of -41%. The sector median D/E is 0%, putting REED'S, INC. at higher leverage than the typical peer. Elevated leverage in combination with the current margin profile warrants close monitoring for any deterioration in debt-servicing capacity.
Weak momentum (25th percentile) suggests institutional selling pressure and unfavorable technical dynamics that may persist.
Above 50MA
37.18%
Net New Highs
+51081
PALO ALTO, Calif., January 29, 2026--Navan (NASDAQ: NAVN), the leading all-in-one business travel, payments, and expense management platform, today announced that it will begin transitioning Reed & Mackay customers to the Navan platform. As part of this transition, Reed & Mackay’s world-renowned service will become the foundation for a new premium offering from Navan, all while ensuring customers continue to receive the white-glove service they value today. By combining Navan’s industry-leading

Gainers Sera Prognostics, Inc. (NASDAQ: SERA) shares surged 63.4% to $2.11 after the company announced top-line data from the AVERT PRETERM TRIAL. TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares climbed 63.4% to $0.7684 after the company requested the withdrawal of a registration statement, saying it has determined not to pursue the sale of securities at this time. Tenon Medical, Inc. (NASDAQ: TNON) rose 36.4% to $1.3513 after dropping 10% on Tuesday. Tenon Medical, during November, posted a Q3 loss of $0.28 per share. Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares rose 34.6% to $0.8771 after dropping 26% on Tuesday. Vallon Pharmaceuticals and GRI Bio recently announced they entered into a merger agreement. Titan Medical Inc. (NASDAQ: TMDI) jumped 33.8% to $0.18. The Nasdaq recently notified Titan Medical regarding Audit Committee requirements. Roblox Corporation (NYSE: RBLX) shares climbed 24.8% to $44.54 after the company reported better-than-expected Q4 sales results. NerdWallet, Inc. (NASDAQ: NRDS) surged 22% to $17.40 following strong quarterly results. Cerberus Cyber Sentinel Corporation (NASDAQ: CISO) jumped 21% to $0.9300. Cerberus Sentinel recently announced a proposed public offering of common stock. Upstart Holdings, Inc. (NASDAQ: UPST) gained 20.6% to $20.34 after the company reported better-than-expected financial results but issued weak guidance. The Trade Desk, Inc. (NASDAQ: TTD) gained 19.4% to $59.76 after the company reported better-than-expected Q4 adjusted results and issued Q1 revenue guidance above estimates. The company also announced a $700 million buyback. Atlis Motor Vehicles, Inc. (NASDAQ: AMV) jumped 20% to $1.86. Sidus Space, Inc. (NASDAQ: SIDU) gained 16% to $0.6778 after the company announced a $2.5 million agreement with the Netherlands for laser communication satellite. Humanigen, Inc. (NASDAQ: HGEN) rose 15.3% to $0.2075. Humanigen received a notice of allowance for its U.S. patent application 16/652,977 titled "Methods of Treating Immunotherapy-Related Toxicity Using a GM-CSF Antagonist." Vapotherm, Inc. (NYSE: VAPO) jumped 15% to $1.07. Vapotherm VP, Controller and CAO Dorota McKay acquired a total of 19,047 shares at an average price of $1.05. Digital Ally, ...

Gainers Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) shares surged 85% to $2.2200. Sonoma Pharmaceuticals and EMC Pharma announced Department of Defense DAPA registration for Microcyn(R) Rx products. Ensysce Biosciences, Inc. (NASDAQ: ENSC) gained 60% to $1.08 after the company reported initiation of final stage of opioid overdose protection Phase 1 study. Plutonian Acquisition Corp. (NASDAQ: PLTNR) surged 36.5% to $0.2320. First Wave BioPharma, Inc. (NASDAQ: FWBI) shares jumped 36% to $6.01 after the company announced expansion of adrulipase intellectual property portfolio. eHealth, Inc. (NASDAQ: EHTH) gained 26.9% to $6.88 after the company raised its preliminary FY22 revenue guidance. Stride, Inc. (NYSE: LRN) shares gained 21.2% to $38.79 after the company announced better-than-expected Q2 results. Xilio Therapeutics, Inc. (NASDAQ: XLO) jumped 20.6% to $3.4962. Millicom International Cellular S.A. (NASDAQ: TIGO) gained 16.2% to $17.23 following a report suggesting Apollo and Marcelo Claure are exploring a buyout of the company. Esports Entertainment Group, Inc. (NASDAQ: GMBL) rose 15.6% to $0.1826 after jumping 88% on Tuesday. The company, last month, named Alex Igelman as Chief Executive Officer. GasLog Partners LP (NYSE: GLOP) gained 14.6% to $8.00. GasLog Partners is expected to report Q4 results on Jan. 26, 2023. Inhibikase Therapeutics, Inc. (NASDAQ: IKT) gained 13.2% to $1.03 as the company said the FDA has lifted full clinical hold on IkT-148009 in Parkinson's Disease. iPower Inc. (NASDAQ: IPW) gained 13% to $0.87. Kidpik Corp. (NASDAQ: PIK) jumped 11.5% to $1.07. Inpixon (NASDAQ: INPX) shares rose 10.9% to $1.7305 after gaining 6% on Tuesday. Inpixon, last month, secured a purchase order valued at over $1m for its RTLS products from ...

Westrock Coffee Company (WEST) delivered earnings and revenue surprises of -550% and 4.04%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Reed's reported a challenging Q2 2025, with revenue dropping 20.2% to $9.5 million, missing analyst estimates. The company experienced significant margin decline due to a $1.6 million inventory write-off and increased operational expenses, resulting in a wider net loss.